Literature DB >> 13974840

Reovirus infections in human volunteers.

L ROSEN, H E EVANS, A SPICKARD.   

Abstract

Entities:  

Keywords:  ANIMAL VIRUSES; VIRUS DISEASES

Mesh：

Year:  1963        PMID： 13974840     DOI： 10.1093/oxfordjournals.aje.a120293

Source DB:  PubMed          Journal:  Am J Hyg        ISSN： 0096-5294


× No keyword cloud information.
  38 in total

1.  Reovirus as a novel oncolytic agent.

Authors:  K L Norman; P W Lee
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

2.  REO-10: a phase I study of intravenous reovirus and docetaxel in patients with advanced cancer.

Authors:  Charles Comins; James Spicer; Andrew Protheroe; Victoria Roulstone; Katie Twigger; Christine M White; Richard Vile; Alan Melcher; Matt C Coffey; Karl L Mettinger; Gerard Nuovo; David E Cohn; Mitch Phelps; Kevin J Harrington; Hardev S Pandha
Journal:  Clin Cancer Res       Date:  2010-10-06       Impact factor: 12.531

Review 3.  UNDERSTANDING OF VIRAL RESPIRATORY ILLNESSES PROVIDED BY EXPERIMENTS IN VOLUNTEERS.

Authors:  G G JACKSON
Journal:  Bacteriol Rev       Date:  1964-12

4.  REOVIRUS ENCEPHALITIS IN NEWBORN MICE: AN ELECTRON MICROSCOPIC AND VIRUS ASSAY STUDY.

Authors:  A B JENSON; E R RABIN; C A PHILLIPS; J L MELNICK
Journal:  Am J Pathol       Date:  1965-08       Impact factor: 4.307

5.  A phase I trial and viral clearance study of reovirus (Reolysin) in children with relapsed or refractory extra-cranial solid tumors: a Children's Oncology Group Phase I Consortium report.

Authors:  E Anders Kolb; Valerie Sampson; Deborah Stabley; Alexa Walter; Katia Sol-Church; Timothy Cripe; Pooja Hingorani; Charlotte Hsieh Ahern; Brenda J Weigel; James Zwiebel; Susan M Blaney
Journal:  Pediatr Blood Cancer       Date:  2015-02-27       Impact factor: 3.167

6.  Phase I/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignancies.

Authors:  Eleni M Karapanagiotou; Victoria Roulstone; Katie Twigger; Mercel Ball; Maryanne Tanay; Chris Nutting; Kate Newbold; Martin E Gore; James Larkin; Konstantinos N Syrigos; Matt Coffey; Brad Thompson; Karl Mettinger; Richard G Vile; Hardev S Pandha; Geoff D Hall; Alan A Melcher; John Chester; Kevin J Harrington
Journal:  Clin Cancer Res       Date:  2012-02-07       Impact factor: 12.531

7.  Reovirus-associated meningoencephalomyelitis in baboons.

Authors:  S Kumar; E J Dick; Y R Bommineni; A Yang; J Mubiru; G B Hubbard; M A Owston
Journal:  Vet Pathol       Date:  2013-07-26       Impact factor: 2.221

Review 8.  Oncolytic viruses: From bench to bedside with a focus on safety.

Authors:  Pascal R A Buijs; Judith H E Verhagen; Casper H J van Eijck; Bernadette G van den Hoogen
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 9.  Making sense of current and emerging therapies in pancreatic cancer: balancing benefit and value.

Authors:  Daniel H Ahn; Andrew H Ko; Neal J Meropol; Tanios S Bekaii-Saab
Journal:  Am Soc Clin Oncol Educ Book       Date:  2015

10.  Improved systemic delivery of oncolytic reovirus to established tumors using preconditioning with cyclophosphamide-mediated Treg modulation and interleukin-2.

Authors:  Timothy Kottke; Jill Thompson; Rosa Maria Diaz; Jose Pulido; Candice Willmon; Matt Coffey; Peter Selby; Alan Melcher; Kevin Harrington; Richard G Vile
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.